The Defense Supply Center Philadelphia is soliciting proposals for the supply of Zanamivir for inhalation (Relenza®). This acquisition is authorized under 10 USC 2304 (c) 1, Only One Responsible Source. The one responsible source being solicited is GlaxoSmithKline, LLC. Approximately 740,464 PG are included in this requirement. A definite quantity contract is proposed. Contractor shall deliver to various locations provided at time of award. Solicitation requests may be transmitted via email to
[email protected] and by phone (215)737-2836.
This notice is hereby amended to increase the required quantity from 740,464 packages to 982,384 for an increase of 241,920 packages.
Bid Protests Not Available